Literature DB >> 11716500

Radiation-inducible hSNK gene is transcriptionally regulated by p53 binding homology element in human thyroid cells.

Y Shimizu-Yoshida1, K Sugiyama, T Rogounovitch, A Ohtsuru, H Namba, V Saenko, S Yamashita.   

Abstract

We identified a species relevant to polo-like kinase family, a human homologue of mouse serum-inducible kinase, hSNK gene, whose mRNA expression was rapidly increased in cultured human thyroid cells after X-ray irradiation. The cDNA cloning and genomic analysis of the hSNK gene showed the presence of 14 exons spanning over 6 kb of genomic DNA that encodes a 2.9-kb mRNA product. Promoter analysis demonstrated possible existence of a radiation-responsive element in the p53 binding homology element (p53RE) localized to near upstream of basal promoter of the hSNK gene. Nuclear protein extracts from HeLa and various human thyroid carcinoma cell lines bound selectively to p53RE. Anti-p53 or anti-p73 antibodies, however, failed to recognize the p53RE-protein complex formed in the presence of such nuclear extracts. These results suggest that radiation-responsive transcription factor(s) directly participates in the regulation of hSNK gene expression via the binding to p53RE in promoter region.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716500     DOI: 10.1006/bbrc.2001.5993

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  The gene expression sequence of radiated mucosa in an animal mucositis model.

Authors:  S T Sonis; J Scherer; S Phelan; C A Lucey; J E Barron; K E O'Donnell; R J Brennan; H Pan; P Busse; J D Haley
Journal:  Cell Prolif       Date:  2002-08       Impact factor: 6.831

Review 2.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

Review 3.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 4.  The Paradox of p53: What, How, and Why?

Authors:  Yael Aylon; Moshe Oren
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding.

Authors:  Jeanette Schwarz; Stefanie Schmidt; Olga Will; Tomas Koudelka; Kaja Köhler; Melanie Boss; Björn Rabe; Andreas Tholey; Jürgen Scheller; Dirk Schmidt-Arras; Michael Schwake; Stefan Rose-John; Athena Chalaris
Journal:  J Biol Chem       Date:  2013-12-13       Impact factor: 5.157

6.  Polo-like kinases mediate cell survival in mitochondrial dysfunction.

Authors:  Takumi Matsumoto; Ping-Yuan Wang; Wenzhe Ma; Ho Joong Sung; Satoaki Matoba; Paul M Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-11       Impact factor: 11.205

7.  PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.

Authors:  Zheng Bo Hu; Xiao Hong Liao; Zun Ying Xu; Xiao Yang; Chao Dong; An Min Jin; Hai Lu
Journal:  Cancer Med       Date:  2015-12-02       Impact factor: 4.452

8.  Design and Synthesis of a Novel PLK1 Inhibitor Scaffold Using a Hybridized 3D-QSAR Model.

Authors:  Youri Oh; Hoyong Jung; Hyejin Kim; Jihyun Baek; Joonhong Jun; Hyunwook Cho; Daseul Im; Jung-Mi Hah
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

9.  Mitotic Kinases and p53 Signaling.

Authors:  Geun-Hyoung Ha; Eun-Kyoung Yim Breuer
Journal:  Biochem Res Int       Date:  2012-07-19

10.  Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73.

Authors:  ZhengBo Hu; ZunYing Xu; XiaoHong Liao; Xiao Yang; Cao Dong; KuaDi Luk; AnMin Jin; Hai Lu
Journal:  Onco Targets Ther       Date:  2015-11-20       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.